104
Communications to the Editor
Chem. Pharm. Bull. 51(1) 104—106 (2003)
Vol. 51, No. 1
the secondary alcohol 4, [a]D23 ꢁ73.2° (cꢂ1.3, CHCl3), di-
astereoselectively which was transformed into the benzyl
ether 5, [a]D25 ꢀ20.7° (cꢂ1.3, CHCl3), under standard condi-
tions. On sequential removal of the MOM-protecting group
and oxidation, the ether 5 gave the ketone 7, [a]D24 ꢁ135.8°
(cꢂ1.6, CHCl3), via the secondary alcohol 6, [a]D24 ꢁ29.4°
(cꢂ1.5, CHCl3). Owing to its molecular bias, the ketone 7 al-
lowed diastereoselective installation of the quaternary stere-
ogenic center to give the single dialkylated ketone 8, [a]D24
ꢁ63.6° (cꢂ1.4, CHCl3), by sequential methylation and ally-
lation under basic conditions. After debenzylation with 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ),6,20) the resulting
keto-alcohol 9, [a]D23 ꢀ38.7° (cꢂ1.4, CHCl3), was oxidized
to the b-diketone 10, [a]D24 ꢁ228.4° (cꢂ1.4, CHCl3), with
pyridinium chlorochromate (PCC). As observed in the previ-
ously reported synthesis of the C/D-ring moiety of cal-
citriol,2,3) and (ꢀ)-vernolepine,6) exposure of the diketone 10
to sodium methoxide in methanol induced a facile regiose-
lective retro-Dieckmann reaction to afford the single cy-
clopentanone 12, [a]D24 ꢀ96.6° (cꢂ1.3, CHCl3), in excellent
yield. The observed regioselective cleavage may be due to
the steric environment of the two carbonyl functionalities in
which the less congested cyclohexanone carbonyl was prefer-
entially attacked by methoxide ion to generate a transient b-
keto-alkoxide intermediate 11 to lead exclusively to the cy-
clopentanone 12 destined for the BCD-ring moiety of (ꢀ)-
estrone 1 (Fig. 2).
A New Route to (ꢀ)-Estrone Using a
Bicyclo[3.2.1]octane Chiral Building
Block
Keisuke HANADA, Norio MIYAZAWA, and
Kunio OGASAWARA*
Pharmaceutical Institute, Tohoku University; Aobayama, Sendai
980–8578, Japan.
Received November 5, 2002; accepted December 3, 2002
A new route to (ꢀ)-estrone has been developed starting from
the chiral building block having a bicyclo[3.2.1]octane frame-
work based on the inherent stereochemical chemical nature of
the chiral building block.
Key words chiral building block; diastereo-controlled synthesis; aldol
reaction; Dieckmann condensation; steroid
We have recently developed an efficient preparation of the
chiral building block 2 by a route involving either an enzy-
matic1) or a chemical2) resolution step. Because of its inher-
ent stereochemical and chemical nature with a sterically bi-
ased structure, it serves as a versatile chiral building block
and has already been used in the efficient stereocontrolled
syntheses of the antibiotic diterpene (ꢀ)-ferruginol,1) the cal-
citriol A-ring3) and C/D-ring2) precursors, the analgesic alka-
loid (ꢁ)-morphine4) and the structurally related morphinan
alkaloid (ꢁ)-O-methylpallidinine,5) the antitumor sesquiter-
pene (ꢀ)-vernolepin,6) and the 18-yohimbones.7) We have
now attempted its conversion into the representative estro-
genic steroid hormone (ꢀ)-estrone 18—15) applying the same
synthetic methodology employed in the syntheses of the
above mentioned natural products. We report here a new
route leading to (ꢀ)-estrone 1 starting with the building
block (ꢁ)-2 by employing the regioselective retro-Dieck-
mann reaction and the ring-closing metathesis16—19) as key
steps (Fig. 1).
In order to construct the C-ring moiety of (ꢀ)-estrone 1,
the cyclopentanone 12 was refluxed with the Grubbs’ reagent
in dichloromethane to initiate the ring-closing metathesis.
The expected reaction took place readily to give the hydroin-
danone 13, [a]D23 ꢀ90.4° (cꢂ1.4, CHCl3), the C/D-ring moi-
ety of (ꢀ)-estrone 1, in excellent yield. The bicyclic ketone
Because of its sterically biased structure, the bicyclic
enone (ꢁ)-2 exhibited convex-face selectivity to allow di-
astereoselective introduction of the vinyl functionality at the
b-position to give the single ketone 3, [a]D24 ꢁ101.9° (cꢂ1.5,
CHCl3). Reduction of 3 with sodium borohydride afforded
Fig. 1
Fig. 2.
Reagents and conditions: i) vinylmagnesium bromide, CuBr–Me2S, TMSCl, HMPA, THF, ꢁ78 °C then TBAF (93%). ii) NaBH4, MeOH, ꢁ78—ꢁ30 °C (92%), iii) BnBr, NaH,
Bu4NI, THF, reflux (80%), iv) HCl–MeOH (94%). v) PCC, CH2Cl2 (94%). vi) MeI, NaH, THF, then allyl bromide, ButOK, THF (77%, 2 steps). vii) DDQ, H2O, CH2Cl2 (77%).
viii) PCC, CH2Cl2 (94%). ix) NaOMe, MeOH (93%).
∗ To whom correspondence should be addressed. e-mail: konol@mail.cc.tohoku.ac.jp
© 2003 Pharmaceutical Society of Japan